Immunome, Inc. (IMNM)
21.50
+0.32
(+1.51%)
USD |
NASDAQ |
Dec 31, 16:00
21.50
0.00 (0.00%)
After-Hours: 19:15
Immunome Market Cap: 1.972B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 962.16B |
| Amphastar Pharmaceuticals, Inc. | 1.231B |
| Relay Therapeutics, Inc. | 1.472B |
| Prelude Therapeutics, Inc. | 181.37M |
| Context Therapeutics, Inc. | 135.06M |
Market Cap Related Metrics
| PS Ratio | 176.08 |
| Price to Book Value | 7.471 |
| Price | 21.50 |
| Earnings Yield | -13.75% |